A phase 1, randomized, placebo-controlled, dose-ranging study to evaluate the safety and immunogenicity of an mRNA-based chikungunya virus vaccine in healthy adults.
暂无分享,去创建一个
S. Weaver | C. Shaw | T. Brasel | A. August | L. Panther | Honghong Zhou | S. Bart | C. Knightly | P. Booth